Neurology Specialists

ChristianaCare

Postpartum Hemorrhage

Hemorrhage

Cancer

Squamous Cell Carcinoma of Head and Neck

Gemcitabine

Paclitaxel

Carboplatin

Cisplatin

5-FU

Pembrolizumab

Alydia Health

Genmab

condition

allSponsorName

BioNTech

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

To evaluate the safety and anti-tumor activity of GEN1042 in patients with metastatic or locally advanced solid tumors.

GEN1042 Safety Trial and Anti-tumor Activity in Subjects With Malignant Solid Tumors

ChristianaCare | Neurology Specialists

Site insights

Work at this site?

Active trials

GEN1042 Safety Trial and Anti-tumor Activity in Subjects With Malignant Solid Tumors

Trial sponsors